Bill could trim 340B eligibility | GLP-1s hinder common procedure: Study | Pharmacist pay by state | J&J to buy drug for $1.25B | New pharmacy tech group taps president | Texas hospital installs holograms May 28, 2024 Ozempic curbs kidney disease; Novo Nordisk defends price | New therapy ...
Seifert, Pharm.D.; Texas Tech University Health Sciences Center, Lubbock, TX. PURPOSE: Fluoroquinolone antimicrobial medications (FQs) have been speculated to influence the risk of Torsades de pointes (Tdp). Methods of evaluating this risk are varied and not systematic. QTc-interval prolongation, ...